Anm Adaptive Neuromodulation GmbH
GermanyFDA applicant, unverified
- Devices
- 1
What Anm Adaptive Neuromodulation GmbH makes
Anm Adaptive Neuromodulation GmbH manufactures the Tinnitus Therapy System ANM T30 CR, a device designed for neuromodulation to address chronic tinnitus symptoms.
The company’s portfolio is regulated under Class II devices in the US, with the Tinnitus Therapy System ANM T30 CR listed via the FDA’s 510(k) pathway. The manufacturer is based in the United States.
Catalogue
Tinnitus Therapy System Anm T30 Cr Ref K112752
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Anm Adaptive Neuromodulation GmbH have in the registry?
The registry currently lists 1 device for Anm Adaptive Neuromodulation GmbH. Devices recorded under merged duplicate company entries are counted once.
Which registries list Anm Adaptive Neuromodulation GmbH's devices?
Among its 1 most recently registered device, Anm Adaptive Neuromodulation GmbH has devices listed in FDA 510(k) (1 device).
What risk classes do Anm Adaptive Neuromodulation GmbH's devices fall under?
Among its 1 most recently registered device, the classes recorded for Anm Adaptive Neuromodulation GmbH's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Anm Adaptive Neuromodulation GmbH in the registry?
The most recently registered devices listed for Anm Adaptive Neuromodulation GmbH include TINNITUS THERAPY SYSTEM ANM T30 CR.